Title : Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells.

Pub. Date : 2018 Sep

PMID : 29959200






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The second, arsenic trioxide (ATO), at therapeutically achievable concentrations, reduces the level of FLT3-ITD and Mcl-1 proteins, and induces apoptosis in leukemic cell lines and in primary cells expressing FLT3-ITD. Arsenic Trioxide MCL1 apoptosis regulator, BCL2 family member Homo sapiens
2 The second, arsenic trioxide (ATO), at therapeutically achievable concentrations, reduces the level of FLT3-ITD and Mcl-1 proteins, and induces apoptosis in leukemic cell lines and in primary cells expressing FLT3-ITD. Arsenic Trioxide MCL1 apoptosis regulator, BCL2 family member Homo sapiens
3 When ATO is combined with Sorafenib, GSK3beta is activated, Mcl-1 is further reduced, and proapoptotic proteins Bak and Bax are activated. Arsenic Trioxide MCL1 apoptosis regulator, BCL2 family member Homo sapiens